Cerebrovascular incidents differ in patients with permanent and paroxysmal atrial fibrillation.
Staszewski
Jacek
J
Neurological Department, Military Medical Institute, Szaserow, Warsaw, Poland. staszej@amwaw.edu.pl
Staszewska
Marzena
M
Kotowicz
Jerzy
J
Brodacki
Bogdan
B
Tomczykiewicz
Kazimierz
K
Stepien
Adam
A
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D020520:Brain Infarction / Q000209:etiology / Q000401:mortality; D005069:Evaluation Studies as Topic; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000209:etiology / Q000401:mortality; D020766:Intracranial Embolism / Q000209:etiology / Q000401:mortality; D020767:Intracranial Thrombosis / Q000209:etiology / Q000401:mortality; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000401:mortality; D008297:Male; D011044:Poland; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000209:etiology* / Q000401:mortality* / Q000517:prevention & control; D013614:Tachycardia, Paroxysmal / Q000150:complications* / Q000188:drug therapy
D000925:Anticoagulants